Among the 33 cancers, the top three cancers with the most remarkable correlation between PDIA5 expression and stromal score were lower-grade glioma (LGG), BLCA, and thymoma (THYM), the top three tumors whose PDIA5 expression was most notably associated with immune score were LGG, PRAD and BLCA. Here, PDIA5 is linked to prostate adenocarcinoma.